EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy

Sarah Collet iD, Noor C Gieles iD, Chantal M Wiepjes iD, Annemieke C Heijboer iD, Tim Reyns, Tom Fiers iD, Bruno Lapauw iD, Martin den Heijer iD, Guy T'Sjoen iD

The Journal of Clinical Endocrinology & Metabolism · 17.01.2023 · 108 (2) · 331-338

DOI: 10.1210/clinem/dgac576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 06.10.2022. Verfasst von Sarah Collet und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Ghent University Hospital, Ghent 9000, Belgium. Hauptthemen laut MEDLINE: Androgens, Transgender Persons. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Initiating feminizing gender-affirming hormone therapy (GAHT) in transgender women causes a steep decline in serum testosterone. It is unknown if testosterone concentrations change further and whether adrenal androgen levels change during feminizing GAHT and after gonadectomy. This limits clinical decision making in transgender women with symptoms attributed to GAHT or gonadectomy.

Methods

Transgender women (n = 275) initiating estradiol and cyproterone acetate (CPA) were included at baseline, and had follow-up visits after 3 months, 12 months, and 2 to 4 years. During follow-up, 49.5% of transgender women underwent a gonadectomy. Total testosterone (TT), dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEAS), and androstenedione (A4) were measured using liquid chromatography tandem mass spectrometry.

Results

After 3 months of GAHT, mean TT, calculated free testosterone (cFT), and A4 decreased by 18.4 nmol/L (95% CI, −19.4 to −17.4, P < 0.001 [ie, −97.1%]), 383 pmol/L (95% CI, −405 to −362, P < 0.001 [ie, −98.3%]), and 1.2 nmol/L (95% CI, −1.4 to −1.0, P < 0.001 [ie, −36.5%]), respectively, and remained stable thereafter. DHEA and DHEAS decreased by 7.4 nmol/L (95% CI, −9.7 to −5.1 [ie, −28.0%]) and 1.8 µmol/L (95% CI, −2.2 to −1.4 [ie, −20.1%]), respectively, after 1 year and did not change thereafter. After gonadectomy, CPA therapy is stopped, which induced no further change in TT, cFT, DHEA, DHEAS, and A4 compared with those who did not undergo gonadectomy.

Conclusions

Our findings confirm that after an initial drop, testosterone levels in transgender women remain stable. Adrenal androgens decrease in the first year of CPA and estrogen supplementation and remain unchanged after gonadectomy. Androgens did not change after gonadectomy and cessation of CPA. Correlates with clinical symptoms remain to be elucidated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AndrogensTransgender PersonsFemaleHumansTestosteroneAndrostenedioneCyproterone AcetateDehydroepiandrosteroneDehydroepiandrosterone SulfateMale

Stichwörter der Autor:innen

androgensgender-affirming hormone therapygonadectomyliquid chromatographytandem mass spectrometrytestosteronetransgender women

Substanzen

AndrogensTestosteroneAndrostenedioneCyproterone AcetateDehydroepiandrosteroneDehydroepiandrosterone Sulfate

Autor:innen und Institutionen

  • Department of Endocrinology, Ghent University Hospital, Ghent 9000, Belgium.
  • Department of Internal Medicine and Paediatrics, Ghent University, Ghent 9000, Belgium.
  • Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Endocrinology, Center of Expertise on Gender Dysphoria, Amsterdam 1081 HV, The Netherlands.
  • Amsterdam Public Health, Personalized Medicine, Amsterdam, The Netherlands.
  • Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam 1081 HV, The Netherlands.
  • Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam 1105 AZ, The Netherlands.

ORCID-Profile: Sarah Collet, Noor C Gieles, Chantal M Wiepjes, Annemieke C Heijboer, Tom Fiers, Bruno Lapauw, Martin den Heijer, Guy T'Sjoen

Zitieren

APA

Collet, S., Gieles, N. C., Wiepjes, C. M., Heijboer, A. C., Reyns, T., Fiers, T., Lapauw, B., den Heijer, M., & T'Sjoen, G. (2023). Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy. The Journal of Clinical Endocrinology & Metabolism, 108(2), 331-338. https://doi.org/10.1210/clinem/dgac576

Vancouver

Collet S, Gieles NC, Wiepjes CM, Heijboer AC, Reyns T, Fiers T, et al. Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy. The Journal of Clinical Endocrinology & Metabolism. 2023;108(2):331-338. doi:10.1210/clinem/dgac576

BibTeX
@article{Collet2023,
  author = {Collet, Sarah and Gieles, Noor C and Wiepjes, Chantal M and Heijboer, Annemieke C and Reyns, Tim and Fiers, Tom and Lapauw, Bruno and den Heijer, Martin and T'Sjoen, Guy},
  title = {Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  volume = {108},
  number = {2},
  pages = {331--338},
  doi = {10.1210/clinem/dgac576}
}
Kostenlos starten →